APA (7th ed.) Citation

Michels, S., & Bischoff, H. (2019). Safety and efficacy of crizotinib in patients with advanced or metastatic ROS1-rearranged lung cancer (EUCROSS): A European phase II clinical trial. Journal of thoracic oncology, 14(7), . https://doi.org/10.1016/j.jtho.2019.03.020

Chicago Style (17th ed.) Citation

Michels, Sebastian, and Helge Bischoff. "Safety and Efficacy of Crizotinib in Patients with Advanced or Metastatic ROS1-rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial." Journal of Thoracic Oncology 14, no. 7 (2019). https://doi.org/10.1016/j.jtho.2019.03.020.

MLA (9th ed.) Citation

Michels, Sebastian, and Helge Bischoff. "Safety and Efficacy of Crizotinib in Patients with Advanced or Metastatic ROS1-rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial." Journal of Thoracic Oncology, vol. 14, no. 7, 2019, https://doi.org/10.1016/j.jtho.2019.03.020.